Home » Stocks » DXR

Daxor Corporation (DXR)

Stock Price: $11.42 USD -0.11 (-0.91%)
Updated Mar 2, 2021 4:00 PM EST - Market closed
Market Cap 47.08M
Revenue (ttm) 264,440
Net Income (ttm) n/a
Shares Out 3.89M
EPS (ttm) -0.42
PE Ratio n/a
Forward PE n/a
Dividend $0.03
Dividend Yield 0.26%
Trading Day March 2
Last Price $11.42
Previous Close $11.53
Change ($) -0.11
Change (%) -0.91%
Day's Open 11.56
Day's Range 11.42 - 11.75
Day's Volume 1,785
52-Week Range 8.47 - 24.08

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
GlobeNewsWire - 4 days ago

Revenues of Operating Division Increase by 50.4%

GlobeNewsWire - 1 week ago

Important Milestone for International Distribution

GlobeNewsWire - 3 weeks ago

NEW YORK, Feb. 05, 2021 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), the global leader in blood volume measurement technology, announces today that it has been awarded a grant from t...

GlobeNewsWire - 3 weeks ago

Study Presented At the Society for Critical Care Medicine (SCCM) 50th Congress

GlobeNewsWire - 1 month ago

NEW YORK, Jan. 13, 2021 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), the global leader in blood volume measurement technology (organized as an investment company with fully-owned inn...

GlobeNewsWire - 1 month ago

NEW YORK, Jan. 08, 2021 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), the global leader in blood volume measurement technology (organized as an investment company with fully-owned inn...

GlobeNewsWire - 2 months ago

NEW YORK, NY, Dec. 10, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood v...

GlobeNewsWire - 2 months ago

NEW YORK, NY, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood v...

GlobeNewsWire - 3 months ago

NEW YORK, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volum...

GlobeNewsWire - 4 months ago

COVID-19 Investigation Continues at OHSU to Study Hospitalized Patients Utilizing Daxor's Blood Volume Analysis Technology

GlobeNewsWire - 4 months ago

NEW YORK, NY, Oct. 12, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood v...

GlobeNewsWire - 4 months ago

NEW YORK, Oct. 06, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volum...

GlobeNewsWire - 4 months ago

NEW YORK, Oct. 05, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volum...

GlobeNewsWire - 5 months ago

NEW YORK, Oct. 02, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volum...

GlobeNewsWire - 5 months ago

NEW YORK, Sept. 28, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood vo...

GlobeNewsWire - 5 months ago

NEW YORK, Sept. 15, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood ...

GlobeNewsWire - 5 months ago

NEW YORK, Sept. 10, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood ...

GlobeNewsWire - 6 months ago

NEW YORK, Aug. 31, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood vol...

GlobeNewsWire - 6 months ago

NEW YORK, Aug. 04, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood vol...

GlobeNewsWire - 7 months ago

NEW YORK, July 20, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE American: DXR) (“Daxor” or the “Company”), an investment company with innovative medical instrumentation and biotechnology...

GlobeNewsWire - 7 months ago

Enrollment Commences Using the BVA-100 ® Diagnostic Blood Test

GlobeNewsWire - 7 months ago

COVID-19 Investigation Commences at NYU Langone Health with Daxor’s Blood Volume Analysis Technology

GlobeNewsWire - 7 months ago

NEW YORK, July 08, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood vol...

GlobeNewsWire - 8 months ago

NEW YORK, June 30, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood vol...

GlobeNewsWire - 9 months ago

NEW YORK, May 26, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volu...

GlobeNewsWire - 9 months ago

NEW YORK, May 22, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volu...

GlobeNewsWire - 10 months ago

New York, April 23, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood vo...

GlobeNewsWire - 11 months ago

New Clinical Protocol for Volume-Guided Therapy Helps Combat Coronavirus

GlobeNewsWire - 11 months ago

NEW YORK, March 09, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood vo...

GlobeNewsWire - 11 months ago

NEW YORK, March 06, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE American: DXR) (“Daxor” or the “Company”), an investment company with innovative medical instrumentation and biotechnolo...

GlobeNewsWire - 11 months ago

NEW YORK, March 03, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE American: DXR) (“Daxor” or the “Company”), an investment company with innovative medical instrumentation and biotechnolog...

GlobeNewsWire - 1 year ago

NEW YORK, March 02, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood vo...

GlobeNewsWire - 1 year ago

NEW YORK, March 02, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood vol...

GlobeNewsWire - 1 year ago

NEW YORK, Feb. 20, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood vol...

GlobeNewsWire - 1 year ago

New Data Scheduled for Presentation on Daxor’s BVA-100®

GlobeNewsWire - 1 year ago

NEW YORK, Nov. 21, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volu...

GlobeNewsWire - 1 year ago

NEW YORK, Nov. 12, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volu...

GlobeNewsWire - 1 year ago

New York, N. Y., Oct. 10, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on bl...

GlobeNewsWire - 1 year ago

NEW YORK, Sept. 24, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood vo...

About DXR

Daxor Corporation, a medical device company, provides biotechnology and cryobanking services in the United States. The company offers BVA-100 Blood Volume Analyzer, an instrument that measures blood volume in human body. BVA-100 Blood Volume Analyzer is used to diagnose and treat patients in various medical and surgical conditions, including congestive heart failure, critical care medicine and intensive care unit medicine, hypertension, syncope, pre-operative blood screening for hidden anemia, anemia in cancer patients, kidney failure, and hypo... [Read more...]

Industry
Asset Management
Founded
1970
CEO
Michael Richard Feldschuh
Stock Exchange
NYSEAMERICAN
Ticker Symbol
DXR
Full Company Profile

Analyst Forecasts

According to one analyst, the rating for Daxor stock is "Buy" and the 12-month stock price forecast is 22.00.

Price Target
$22.00
Analyst Consensus: Buy